NLRP3 and breast cancer: NLRP3 expression and IL-1β secretion of BC tumors promote myeloid-derived suppressor cell (MDSCs) and tumor-associated macrophage (TAM) infiltration to the tumor microenvironment and facilitate an inflammatory microenvironment for cancer progression [44].